|
Originally published In Press as doi:10.1074/jbc.M203239200 on May 2, 2002
J. Biol. Chem., Vol. 277, Issue 28, 25133-25142, July 12, 2002
Regulation of mRNA Expression in Macrophages after
Yersinia enterocolitica Infection
ROLE OF DIFFERENT Yop EFFECTORS*
Nathalie
Sauvonnet §¶,
Bérengère
Pradet-Balade§ ,
Jose A.
Garcia-Sanz , and
Guy R.
Cornelis **
From the Microbial Pathogenesis Unit, Christian de
Duve Institute of Cellular Pathology and Université Catholique de
Louvain, B-1200 Brussels, Belgium, Department of
Immunology and Oncology, Centro Nacional de Biotecnología,
E-28049 Madrid, Spain, and ** Biozentrum der
Universität Basel, CH-4056 Basel, Switzerland
Received for publication, April 4, 2002
 |
ABSTRACT |
The Yop virulon, which comprises a
complete type III secretion system and secreted proteins, allows
bacteria from the genus Yersinia to resist the nonspecific
immune response of the host. This virulon, which is encoded by a
plasmid called pYV in Yersinia enterocolitica, enables
extracellular bacteria to inject six Yop effectors (YopE, -H, -T, -O,
-P, -M) into the host cell. To investigate the role of YopP, YopM, and
the other pYV-encoded factors on the expression of the host cell genes,
we characterized the transcriptome alterations in infected mouse
macrophages using the microarray technique. PU5-1.8 macrophages were
infected either with an avirulent (pYV ), a wild type
(pYV+), or two knockout (yopP and
yopM ) mutants of Y. enterocolitica. Expression alterations in response to Y. enterocolitica infection were monitored for 6657 genes. Among
those, 857 genes were affected, 339 of which were specifically regulated by the action of the Yop virulon. Further analysis of those
339 genes allowed identification of specific targets of YopP, YopM, or
the other pYV-encoded factors. According to these results, the main
action of the Yop virulon is to counteract the host cell
pro-inflammatory response to the infection. YopP participates to this
inhibition, whereas another pYV-encoded factor appears to also be
involved in this down-regulation. Besides, YopM was found to induce the
regulation of genes involved in cell cycle and cell growth, revealing
for the first time an in vitro effect for YopM. In addition
to YopM, other pYV factors distinct from YopP affected the expression
of genes involved in cycling. In conclusion, these results provide new
insight into the mechanisms of Yersinia pathogenicity by
identifying the changes in host genes expression after infection and
highlight the concerted actions of the different Yop effectors.
 |
INTRODUCTION |
Pathogenic bacteria have in common the capacity to overcome the
defense mechanism of their animal host. Various pathogenesis mechanisms
have evolved in parallel to different bacterial life styles,
e.g. extracellular or intracellular. The genus
Yersinia includes three species (Yersinia pestis,
Yersinia pseudotuberculosis, and Yersinia
enterocolitica) that are pathogenic for rodents and humans (1).
Despite their different routes of infection, they are all mainly
extracellular bacteria and share a common tropism for lymphoid tissues
and a capacity to resist the innate immune response. This capacity is
linked to the Yop virulon, a powerful weapon encoded by a virulence
plasmid, called pYV in Y. enterocolitica. This plasmid
encodes a complete type III secretion system and the secreted proteins
(called Yop) with their chaperones (1). In addition, Y. enterocolitica possesses two adhesins, one chromosomally encoded
(invasin) and one pYV-encoded (YadA), which allow a close contact with
eukaryotic cells. This type III secretion system enables extracellular
bacteria adhering to their host cell to insert a pore in the plasma
membrane (involving LcrV, YopB, YopD (2)) and to deliver into the cell
six Yop effectors (YopE, -H, -T, -O, -P, -M) (1). Although the precise
role of some of the six Yops is still not clear, most of them (YopE,
-H, -O, -M) have been shown to be necessary for full virulence of
Y. enterocolitica in the mouse infection model.
The Yop effectors can be divided into three functional groups. Four
Yops (-E, -H, -T, -O) disorganize the host cytoskeleton and block
bacterial phagocytosis by macrophages and polymorphonuclear leukocytes.1 YopE, YopT, and
YopO (YpkA in Y. pestis and Y. pseudotuberculosis) depolymerize the actin filaments by acting on
different Rho GTPases (4-6). YopH dephosphorylates and inactivates
proteins associated to focal adhesion (7, 8). In addition to its role
on cytoskeleton destabilization, YopH was recently shown to inhibit the
phosphatidylinositol 3-kinase pathway, leading to the inhibition of T
lymphocytes proliferation (10).2
YopP (YopJ in Y. pestis and Y. pseudotuberculosis) blocks the NF- B pathway by preventing the
activation of I B kinase . This abolishes the migration of NF- B
to the nucleus, thereby abrogating the onset of the pro-inflammatory
response (11). Besides, YopP inactivates the mitogen-activated protein
kinase (MAPK)3 pathway by
inhibiting MAPK kinases (MKKs) activation, which leads to the
inhibition of the extracellular signal-regulated kinase (ERK), c-Jun
amino-terminal kinase (JNK) and p38, implicated in the activation of
different transcription factors (12). Finally, YopP induces apoptosis
in macrophages, but it is still not clear if this results from a
specific induction of a death pathway (13) or from the inhibition of
NF- B activation (14).
Although YopM plays an important role in pathogenesis in
vivo (15), its function is still unknown. YopM, mainly composed of
leucine-rich repeats, has been shown to migrate into the nucleus (16),
suggesting that it could play a role in the regulation of host cell DNA
transcription or replication. However, thus far such a role remains to
be demonstrated.
Global analysis of gene expression has been used recently to
characterize the response of human neutrophils to Y. pestis
infection (17). Here, we used the microarray technique to define more precisely the individual effects of Yop effectors on host cell mRNA
expression. Because macrophages together with polymorphonuclear leukocytes are the first line of defense against invading organisms, we
decided to analyze gene expression in PU5-1.8 mouse macrophages in
response to Y. enterocolitica infection. To identify
the role of the specific Y. enterocolitica virulence
factors, we compared mRNA expression of non-infected macrophages
with macrophages infected by either an avirulent (pYV ), a
wild type (pYV+), or two knockout bacteria,
yopP , to better characterize the role of YopP
on the regulation of pro-inflammatory genes, and
yopM , to investigate whether this effector is
involved in host cell transcription regulation.
 |
EXPERIMENTAL PROCEDURES |
Cells and Bacteria--
The bacterial strains used were the wild
type Y. enterocolitica serotype O:9 MRS40 (pYV40)
(called pYV+) and its plasmid-cured derivative (called
pYV ) (18). The two single knockout mutants MRS40 (pMSK41)
(called yopP ) and MRS40 (pAB408) (called
yopM ) were described previously (19). All the
strains were currently grown in brain-heart infusion at 25 °C with
the appropriate antibiotics, 35 µg/ml nalidixic acid, and 1 mM arsenite. The PU5-1.8 mouse macrophage-like cell line
was currently cultivated in RPMI 1640 medium (Invitrogen) supplemented
with 2 mM L-glutamine, 10% (v/v) fetal bovine
serum (Invitrogen), 100 units/ml penicillin, and 100 µg/ml
streptomycin at 37 °C in a humidified atmosphere under 5%
CO2.
Before infection Y. enterocolitica were grown in brain-heart
infusion for 2h at 25 °C and then for 30 min at 37 °C to ensure Yop virulon expression. PU5-1.8 cells (1.5 × 107)
were cultivated in cell suspension in the same medium as before but
without antibiotic and infected with bacteria at a multiplicity of
infection of 50:1 for 2.5 h at 37 °C in a humidified atmosphere under 5% CO2.
RNA Extraction and Northern Blot Analysis--
Cytoplasmic RNAs
were prepared using the Nonidet P-40 method as described (20). Briefly,
cells were washed in phosphate-buffered saline (1×) and lysed
in 1 ml of cold Nonidet P-40 lysis buffer supplemented with 20 mM dithiothreitol and 500 units/ml RNasin (Roche Molecular
Biochemicals). Nuclei and mitochondria were removed by brief
centrifugation (20 s at 10,000 × g), and proteins were digested with 200 µg/ml proteinase K (Merck) in the presence of 1%
SDS and 10 mM EDTA. After phenol/chloroform extraction,
RNAs were precipitated with 2.5 volumes of EtOH (100%) in the presence of 0.3 M sodium acetate. RNA quality was checked by
Northern blotting and hybridization with a probe specific for -actin mRNA.
For Northern blot analysis, RNA samples were separated by
electrophoresis through formaldehyde denaturing 1.2% agarose gels and
transferred onto nylon membranes (GeneScreen, PerkinElmer Life
Sciences) (21). rRNA distribution was visualized by methylene blue
staining, and Northern blots were hybridized sequentially with DNA
probes synthesized by random priming using the Megaprime II kit
(Stratagene) and [ -32P]dCTP. Probe templates from
I.M.A.G.E. clones (I.M.A.G.E. clones 1139544, 5325073, 573898, and
4486098) were generated by insert digestion and purification after
verification of the clone identity by sequencing. Hybridizations were
performed overnight at 42 °C followed by washes as described (21),
and the last wash was performed at 65 °C for 30 min in 0.1× SSC
(1× SSC = 0.15 M NaCl and 0.015 M sodium
citrate), 1% SDS. Signals were detected and quantified by
phosphorimaging (Molecular Dynamics, Sunnyvale, CA).
cRNA Synthesis, Affymetrix GeneChip Probe Array Hybridization,
and Data Analysis--
For cRNA synthesis, 30 µg of cytoplasmic RNAs
from either non-infected or infected PU5-1.8 were used as templates
for double-stranded cDNA synthesis using the Superscript Choice
System (Invitrogen) and a T7-(dT)24 primer
according to Affymetrix instructions. After purification,
double-stranded cDNAs were used as template for in vitro
T7 transcription using the Bioarray high yield transcript labeling kit (Enzo). cRNA synthesis yields, as monitored by
spectrophotometry, were highly similar in the different samples
(typically 8-10 µg of cRNA/µg of cytoplasmic RNA used,
corresponding to roughly a 300-fold amplification). 20 µg of each
cRNA population were fragmented. First, 5 µg were used as target for
the Te3 test chip to check the quality of the target. Subsequently, 15 µg were used for hybridization of the murine genome GeneChip probe
arrays U74Av2 (both arrays from Affymetrix). Hybridization, washes,
antibody amplification, and staining were performed using the
Affymetrix fluidics station and scanner following the manufacturer's
instructions. Analysis of the raw data was performed using
Affymetrix Suite software. Further analysis were performed using the
Excel and GeneCluster (available at
www.genome.wi.mit.edu/MPR/software.html) software.
 |
RESULTS AND DISCUSSION |
Preliminary Considerations--
To characterize the specific
effects of the Y. enterocolitica Yop virulon on the host
cell transcriptome, we analyzed gene expression of infected PU5-1.8
murine macrophages. A preliminary kinetic analysis showed that a 2.5-h
infection with wild type (pYV+) Y. enterocolitica was sufficient to elicit a robust effect on the
inflammatory response, as monitored by tumor necrosis factor (TNF- ) mRNA level and induced less than 10% of apoptosis, as monitored by propidium iodide incorporation (data not shown). Because
one early effect of apoptosis induction is the degradation of cellular
mRNAs,4 this point was
critical to ensure extraction of high quality, undegraded cytoplasmic RNAs.
We analyzed mRNA expression from macrophages infected for 2.5 h with pYV , pYV+,
yopP , and yopM
bacteria, and non-infected PU5-1.8 macrophages. After infection, cytoplasmic RNAs were extracted to monitor the variations of mature mRNAs by the Affymetrix GeneChip system. We used the
oligonucleotide probe array MG-U74Av2, which allows measurement of the
expression levels of about 6000 mRNAs and 6000 Expressed Sequence
Tags (EST; for simplification, we use the word "gene" indifferently
for known genes or EST). In each experiment, the number of mRNA
species detected (called "present" by the Affymetrix Suite analysis
software) was about 40-46%, and the analysis was carried out on 6657 genes. In every experiment, the mean signal intensities were
arbitrarily adjusted to 150. The dynamic range of the data as well as
the signal distributions were very similar, all encompassing more than
4 orders of magnitude (Fig. 1), hence
validating the reliability of the microarray experiments. According to
those distributions, the background was empirically set to 20 so that
the genes with data values below this threshold were considered to have
undetectable mRNA expression levels. Furthermore, Affymetrix array
values for most of the so-called "housekeeping genes" such as
-actin and elongation factor 1 (EF1 ) were found to
be similar in the five conditions, coherent with the results
obtained by Northern blot hybridizations (Fig.
2). Those Northern blots were performed
with RNA from three different infection experiments to check the
reproducibility of the results.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Dynamic range of Affymetrix array
hybridization signals. Specific hybridization signals for each
probe set in the Affymetrix GeneChip U74Av2 probe array were sorted by
increasing values and plotted against a running index in the
x axis. Targets were generated from cytoplasmic RNAs
extracted from non-infected mouse PU5-1.8 macrophages (N)
or macrophages infected with pYV , pYV+,
yopP , or yopM
Y. enterocolitica strains. A line
(y = 20) shows the value set as threshold. All values
below were taken as background.
|
|

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 2.
Regulation of mRNA expression as
monitored by Northern blot is in agreement with the Affymetrix data
analysis. 10 µg of total RNA from PU5-1.8 either non-infected
(N) or infected for 2.5h with Y. enterocolitica
pYV ( ), pYV+ (+),
yopP (P),and
yopM (M) were separated by
formaldehyde gel electrophoresis and transferred onto nylon membrane
(see "Experimental Procedures"). Hybridization with probes specific
for elongation factor 1 (EF1 ), -actin, IL-1 ,
TNF- , p75 TNF receptor (TNFR2), small inducible cytokine
A2 (MCP-1), and IL-1 receptor antagonist (IL-1rn)
reveal the specific expression patterns in each condition, which are in
full agreement with the results obtained from Affymetrix array
data.
|
|
Genes Regulated by PU5-1.8 Macrophages in Response to the
Bacterial Infection, Independently of the Yop Virulon--
First we
compared the microarray hybridization data from the non-infected
PU5-1.8 cells with those from cells infected with pYV
or pYV+ bacteria. Genes were considered as not
regulated and, hence, were discarded from the analysis if they did not
show any significant variation of their expression level in the cells
infected by the pYV or the pYV+ bacteria, as
compared with the non-infected cells (i.e. ratio values <2
or difference between the values <30). This yielded a data set of 857 genes regulated upon Y. enterocolitica infection, representing nearly 13% of the 6,657 genes analyzed. To cluster genes
according to the variation pattern of their mRNA level, self-organizing maps (SOMs) analyses were performed using the GeneCluster software (23), resulting in the identification of eight
different groups of genes (Fig. 3 and
www.biozentrum.unibas.ch/cornelis/manuscript/Folder_1.html).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Expression patterns of PU5-1.8 macrophage
genes regulated after Y. enterocolitica
infection. 857 genes whose expression was at least 2-fold
different between non-infected cells (N) and cells infected
by Y. enterocolitica pYV ( ) or
pYV+ (+) were clustered by SOM analysis according to their
expression profile into 8 groups (A-H). The number of genes
related to each cluster is indicated above. The relative
contribution of the different clusters A + B, C + H, E + F, and D + G
to the total regulations is represented schematically by a pie
diagram.
|
|
The first two clusters, called A and B, gathered
518 genes that were similarly expressed in cells infected with
pYV and pYV+ bacteria but differently in the
non-infected cells (Fig. 3). Thus, these variations represented the
PU5-1.8 macrophage response to the bacterial infection, which was not
modulated by the Yop virulon. Supporting this interpretation, we found
numerous genes encoding cytokines and other pro-inflammatory proteins
in the cluster A, which gathers genes up-regulated in
pYV - and pYV+-infected cells (see Folder 1).
These included the small inducible cytokines A3 (SCYA3; J0BB91), A5
(SCYA5; AF0659B7), and A6 (SCYA6; M5800B), interleukin 1 (IL-1) and
(M1B639 and M15131), and the macrophage inflammatory proteins 1b
and 2 (MIP-1b, X62502; MIP-2, X53798), most of which are up-regulated
after infections with bacteria as diverse as Escherichia coli,
Listeria monocytogenes, Bordetella pertussis, or
Salmonella (17, 24-26). As an example, Northern blot
analysis of IL-1 mRNA expression was in complete agreement with
the microarray data (Fig. 2). Besides, cluster A enclosed less
predictable factors also involved in immune response, such as the
complement component C3 (K02782), which plays a central role in
phagocytosis (27), and Fas receptor (M836B9), which is up-regulated in
macrophages after activation, as a mechanism of negative feed-back
(28). In cluster B, corresponding to the cluster A-inverted pattern, we
found numerous genes encoding intracellular signaling proteins among
which the diacylglycerol kinase (GenBankTM
AF085219). Diacylglycerol kinase is involved in
phosphatidylinositol triphosphates synthesis and, although it has
long been considered as a housekeeping gene, recent analysis in mice
reveals that diacylglycerol kinase mRNA is down-regulated after
T lymphocyte activation.5
A previous study of the neutrophil transcriptome during Y. pestis infection showed that some cytokines (namely, SCYA3, MIP-2, IL-1 and - ) are up-regulated in the pCD1
(pYV analogous)-infected neutrophils but not in the
pCD1+ (pYV+ analogous) ones (17). This result
contrasts with our finding that those genes were up-regulated in both
Y. enterocolitica pYV - and
pYV+-infected macrophages (cluster A, Fig. 3).
This discrepancy can be explained by differences between the two
infected cell types (human neutrophils versus mouse
macrophage cell line). Indeed, the same authors show transcriptome
variations between monocytes and neutrophils infected by E. coli (17). This divergence could also result from the fact that
two different Yersinia species were used (Y. pestis
versus Y. enterocolitica). In fact, at least for IL-1 , it was recently reported that its gene was up-regulated in
macrophages infected by wild type Y. enterocolitica (30). Finally, because 60% of the identified regulated genes belong to
clusters A and B, the majority of the alterations in gene expression that take place in Y. enterocolitica-infected cells
represents the macrophage response to the bacterial infection
independently of the Yop virulon (Fig. 3).
Identification of Genes Whose Expression Is Modified by the Yop
Virulon--
The six other clusters (C-H) regrouped 339 genes whose mRNA levels differed in cells infected by the
pYV+ from that infected by the pYV
bacteria (Fig. 3 and
www.biozentrum.unibas.ch/cornelis/manuscript, Folder 1). Those
genes were, thus, specifically regulated by factors encoded by the
Y. enterocolitica pYV plasmid. Strikingly, the majority of
these genes were found in clusters C and F (198 on 339, i.e.
58% of the pYV-regulated genes). These two clusters gathered genes up
(F)- or down (C)-regulated after
pYV infection but on which the pYV-encoded factors
induced a deregulation so that the mRNA expression level in
pYV+-infected cells was similar to that in the non-infected
cells (Fig. 3). This most likely represents a specific mechanism by which Y. enterocolitica counteracts the macrophage
activation, by shutting down the host cell response. Because most of
the genes identified as specifically regulated by the Yop virulon
belong to this category, one of the most important functions
accomplished by the pYV-encoded factors seems to be to counteract the
host cell response to the infection. This is in agreement with previous observations made on neutrophils infected by Y. pestis,
where more genes showed altered expression in
pYV -infected cells than in pYV+-infected ones
(17).
To gain further insight into the mechanism by which the Yop virulon
regulates the host cell transcriptome, PU5-1.8 cells were infected
with the Y. enterocolitica yopP and
yopM strains in which the genes encoding YopP
or YopM have been knocked out. mRNA expression of the 339 genes
previously identified as specifically regulated by pYV-encoded factors
(clusters C-H) were analyzed in non-infected cells and cells infected
with the four Y. enterocolitica strains. Again, SOMs were
generated to cluster genes following their pattern of mRNA
expression. This analysis yielded as many as 24 different clusters,
some of which could not be interpreted by the sole effect of YopP or
YopM or of the other pYV-encoded factors. For this reason, we decided
to concentrate on the patterns that undoubtedly displayed the effect of
either (i) YopP, (ii) YopM, or (iii) the other factors encoded by the pYV plasmid. This global analysis, taking simultaneously into account
the five different conditions, is more stringent than the comparison of
expression profiles two by two (i.e. pYV+
versus yopP ) and, thus, should
yield more reliable results concerning the target genes controlled by
the different Y. enterocolitica effectors.
Specific Changes of Host Gene Expression Dependent on
YopP--
Genes were considered as specifically regulated by YopP
action if they were expressed at similar levels in pYV+ and
yopM -infected cells on one side and in
pYV and yopP -infected cells on
the other side. Four clusters (I, J,
K, L), which represent 59 genes, fulfill this
criterion (Fig. 4, Table I,
www.biozentrum.unibas.ch/cornelis/manuscript/Folder_2.html). Fig. 2
shows the Northern hybridization of two YopP targets, TNF- and TNF
receptor 2, which expression correlates with the profiles determined by
Affymetrix chip hybridization.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Expression patterns of PU5-1.8 macrophage
genes regulated by the action of YopP, YopM, or pYV-encoded factors
distinct from YopP and YopM. The expression profiles of 339 pYV-regulated genes were analyzed in PU5-1.8 either non-infected
(N) or infected by Y. enterocolitica
pYV ( ), pYV+ (+),
yopP (P ), and
yopM (M ). SOM analysis
allowed identification of genes specifically regulated by the action of
(i) YopP, gathered into four clusters (I-L), (ii) YopM, gathered into
three clusters (M-O), and (iii) pYV-encoded factors
distinct from YopP or YopM, gathered into five clusters
(P-T).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
PU5-1.8 macrophage genes regulated by YopP action
Genes specifically modulated by YopP according to their expression
pattern, as monitored by SOM analysis, are listed below together with
their accession number and according to their function. The cluster
(I-L) to which they belong is indicated on the right. In addition, 20 YopP-regulated ESTs, coding for unknown genes, are listed in
complementary information on-line
(www.biozentrum.unibas.ch/cornelis/manuscript, Folder 2).
|
|
For most of the genes identified as YopP targets (clusters I + K = 37 genes), the effect of YopP consisted in restoring the mRNA
expression to the level observed in non-infected cells. The majority of
those genes are involved in the immune response, consistent with the
known capacity of YopP to inhibit the inflammatory response (31). This
is particularly the case for cluster I, which represents all the genes
that were up-regulated in pYV and
yopP -infected cells as compared with the
non-infected cells and the pYV+ and
yopM -infected cells (Fig. 4). These genes code
for cytokines (TNF- ), receptors (TNF receptor 2), signaling
molecules (Traf1), apoptotic modulators (A20), or transcription factors
modulators (junB, I B ), many of which are involved in the
TNF- -signaling pathway (Table I) (32). Strikingly, nearly all the
genes from this cluster were shown to be inducible by NF- B (33)
(Table I). Their down-regulation may thus result from the inhibition
exerted by YopP on I B kinase , which leads to the inhibition of
NF- B activation (12). Thus, these results, coherent with the known
action of YopP, further support the reliability of our microarray data
and demonstrate for the first time that mRNA expression of those
genes is actually down-regulated by the action of YopP in Y. enterocolitica-infected macrophages. Conversely, it should be
noted that not every potential NF- B target induced by
pYV infection appeared to be down-regulated by YopP
(example, IL-1 , MIP-2). This may be explained either by a rather
high stability of their mRNAs, whose level decreased later than
that of TNF- mRNA for instance or by the induction of those
mRNAs by transcription factors other than NF- B. This difference
between YopP actions on the distinct NF- B targets illustrates the
complexity of the cellular regulations, and the need for such a
wide analysis to unravel the targets of a Yop effector.
Another interesting target from cluster I is eIF2B, a key regulator of
protein translation (34), hence suggesting that YopP might inhibit
protein synthesis. Besides, eIF2B activity was shown to be induced by
the MAPK pathway (35), a cascade that is itself inactivated by YopP
(12). As a result, YopP might decrease eIF2B protein and activity
through acting at both the transcriptional and the post-translational
levels. Because the inhibition of eIF2B activity was recently shown to
induce apoptosis (36), those effects might be connected with the
pro-apoptotic function of YopP (19).
Cluster K, corresponding to cluster I inverted pattern,
contained genes that were up-regulated specifically by the action of YopP (Fig. 4). Again, this cluster was rather homogenous as it
gathered mainly genes encoding cell surface proteins (Table I).
In contrast with the previous clusters, clusters J and L gathered genes
for which YopP induced a marked difference in their expression level as
compared with those observed in non-infected cells. Thus, the action of
YopP is not only to restore the expression level to that in the
non-infected cells. For example, genes from cluster L were up-regulated
in pYV+-infected cells as compared with non-infected or
even to the pYV -infected macrophages (Fig. 4). Among
those genes are MAPK phosphatase (MKP-1) and G protein signaling
regulator (RGS2) (Table I). Both proteins are stress-induced, and both
have been implicated in the inhibition of the MAPK pathway (37, 38). It
has been reported that YopP inhibits MAPK by directly inactivating
their upstream kinases (12). Our results suggest the existence of
additional, yet undescribed mechanisms by which YopP could inhibit the
MAPK signaling pathway; that is, by inducing the overexpression of mRNAs encoding proteins able to inhibit MAPK. Genes from cluster J
were down-regulated in a YopP-dependent way. These include
PCMT1 and PNAD, both implicated in protein repair and degradation (39), together with procollagen type IV and junction plakoglobin, involved in
cell-extracellular matrix and cell-cell cohesion (40) (Fig. 4). Hence,
this cluster shows again some homogeneity with regard to the gene
functions and describes new targets of YopP. In conclusion, our
analysis points out the importance of YopP in the inhibition of the
host cell response and allows direct identification of new targets of
this virulence factor.
Specific Changes of Host Gene Expression Dependent on YopM--
As
described for YopP targets, genes were considered as specifically
regulated by YopM action if they shared similar mRNA expression
levels in pYV and yopM -infected
macrophages on one side and in pYV+ and
yopP -infected cells on the other side (Fig. 4,
Table II,
www.biozentrum.unibas.ch/cornelis/manuscript, Folder 2). This led to
the identification of 25 genes, organized into three clusters
(M, N, and O, Fig. 4). For half of
them (clusters N + O = 13 genes), YopM
induced a change in their expression level as compared with those
observed in the non-infected cells (Fig. 4).
View this table:
[in this window]
[in a new window]
|
Table II
PU5-1.8 macrophage genes regulated by YopM action
Genes specifically modulated by YopM according to their expression
pattern, as monitored by SOM analysis, are listed below together with
their accession number and according to their function. The cluster
(M-O) to which they belong is indicated on the right. In addition,
seven YopM-regulated ESTs, coding for unknown genes, are listed in
complementary information on-line
(www.biozentrum.unibas.ch/cornelis/manuscript, Folder 2).
|
|
Most of the genes regulated by YopM action seemed to be related to the
cell cycle and cell growth (Table II). These include genes encoding
proteins involved in DNA replication and repair such as the DNA
mismatch repair protein (MLH1, cluster M) and the checkpoint kinase 2 (CHK2, cluster N), both of which belong to the genome surveillance
network. A defect of these genes can lead to aberrant cell growth (41,
42). Caf-1 (cluster N), which also participates to the general DNA
surveillance, is involved in chromatin assembly and DNA replication
(43). These three genes, involved in DNA maintenance, were all
down-regulated by YopM action (Table II). Furthermore, the
transcription factor B-myb (cluster M) was also down-regulated by the
action of YopM. B-myb is a cell cycle regulator that stimulates
hematopoietic cell proliferation and whose expression is itself
regulated through the cell cycle, being repressed during
G0/early G1 phases, induced in late
G1, and maximal in S phase (44). In addition to those cell
cycle modulators, YopM targets included genes encoding proteins involved in intracellular trafficking, which could also play a role
during the cell cycle. PLD3 (cluster M) is implicated in plasma
membrane traffic (45), whereas STB2 (cluster N) has been involved in
the traffic from the Golgi apparatus to the plasma membrane (46). In
contrast to PLD3 and STB2, which are both down-regulated, dynein
mRNA expression (cluster O) was up-regulated by YopM action. Dynein
is a microtubule motor that plays a central role in vesicular transport
and in chromosome movement. Dynein has recently been shown to be
up-regulated during cellular senescence, suggesting a role for dynein
as a tumor suppressor (47). Altogether these data suggest that YopM
affects several cellular functions that may ultimately perturb cell division.
In addition, YopM induced the down-regulation of the expression of at
least two signaling proteins involved in cell growth. Trio (cluster M)
regulates cytoskeleton reorganization by activating Rho/Rac GTPases and
is necessary for cell migration and growth (48). P52rIpk (cluster M),
although its function is not yet well defined, has been implicated in
the indirect activation of protein kinase R, an inhibitor of stressed
cell growth (49). This shows that, in addition to cell cycle
regulators, YopM affects factors involved in cell growth.
In addition, calsyntenin 1 (cluster O) and Mac-1 (cluster O) were
both up-regulated by YopM action. These two factors are involved in
cell adhesion. In particular, Mac-1 is the C3 receptor involved in
bacterial phagocytosis, thereby playing a crucial role in innate
immunity (50). Although the biological meaning of these up-regulations
remains obscure, they are obviously related neither to cell cycle nor
to cell growth, and they represent another class of YopM target genes.
In conclusion, YopM targets appear to have cellular functions very
distinct from those of YopP targets or from those of the other
pYV-encoded factor targets (see below), as none of those genes is
involved in the pro-inflammatory response. Although YopM clearly
contributes to virulence (15), its role from in vitro experiments remained elusive. This represents the first approach in
which target genes responsive to YopM have been identified. The
mechanism by which YopM affects these target genes remains to be
unraveled. Because YopM is found in the cell nucleus (16), it could
interact directly with proteins involved in mRNA metabolism (i.e. transcription, maturation, export, etc.) to regulate
mRNA expression.
Specific Changes of Host Gene Expression Dependent on pYV-encoded
Factors Distinct from YopP or YopM--
A total of 107 genes
(representing 32% of the pYV-regulated genes) had similar expression
levels in pYV+-, yopM -, and
yopP -infected cells but different expression
levels in the pYV -infected cells. Thus, these genes
appear to be regulated by pYV-encoded factors other than YopP or YopM.
By SOM analysis, these genes were grouped according to their
expression patterns into five different clusters (P,
Q, R, S, T) (Fig. 4, Table
III,
www.biozentrum.unibas.ch/cornelis/manuscript, Folder 2).
View this table:
[in this window]
[in a new window]
|
Table III
PU5-1.8 macrophage genes regulated by the action of pYV-encoded
factors distinct from YopP and YopM
Genes specifically modulated by pYV-encoded factors other than YopP or
YopM according to their expression pattern, as monitored by SOM
analysis, are listed below together with their accession number and
according to their function. The cluster (P-T) to which they belong is
indicated on the right. In addition, 55-regulated ESTs, coding for
unknown genes, are listed in complementary information on line
(www.biozentrum.unibas.ch/cornelis/manuscript, Folder 2).
|
|
Cluster R regrouped genes that were only up-regulated in the
pYV -infected macrophages, so that some pYV-encoded
virulence factors restored their expression to the level observed in
non-infected cells. This cluster groups a set of genes involved in the
inflammatory responses. These include cytokines (granulocyte
colony-stimulating factor, MCP-1, MCP-3) and their modulators
(IL-1rn) as well as other proteins generally induced after bacterial
infection, such as RGS16 and urokinase-type plasminogen activator (51,
52) (Fig. 4, Table III). The expression of these genes was
down-regulated by the action of pYV-encoded proteins other than YopP.
Indeed, Northern blot hybridizations confirmed that mRNA expression
of MCP-1 and IL-1rn, taken as two examples, were actually
down-regulated in the pYV+, yopM ,
and the yopP -infected cells, as compared with
the pYV -infected ones (Fig. 2). This finding reveals
that, in addition to YopP, at least another virulence factor
contributes to the inhibition of the pro-inflammatory response. LcrV is
a pYV-encoded factor with multiple functions. It may represent one of
the candidates responsible for the control of pro-inflammatory response
genes, since long term preincubation of macrophages with purified LcrV has been shown to induce IL-10 secretion, which in turn prevents cytokine release in activated macrophages (53). However, the fact that
IL-10 gene was not expressed under any of the 5 conditions analyzed in
this study raises doubts about the possible control of the genes from
cluster R by LcrV. Another candidate is YopH, which has been recently
demonstrated to suppress the activation of the phosphatidylinositol
3-kinase induced upon Y. enterocolitica infection.2 Phosphatidylinositol 3-kinase is known to
induce different pathways that can lead to the up-regulation of
inflammatory genes such as MCP-1 and urokinase-type plasminogen
activator (54-56) so that its inhibition by YopH could then
down-regulate the inflammatory genes from the cluster R. These results
reveal that Y. enterocolitica overcomes the pro-inflammatory
response through different mechanisms exerted by distinct pYV-encoded factors.
The cluster Q regrouped genes that were specifically up-regulated by a
pYV-encoded factor other than YopP and YopM. It appeared to be very
homogeneous with regard to the function of the genes, in majority
transcription factors (Table III). Among these, five genes belong to
the family of the Kruppel-like transcription factors (Klf9,
Klf4, Klf2, Zpf94, and Zpf36), suggesting that a Y. enterocolitica pYV-encoded factor affects a common regulator of
this family. These Kruppel-like factors are involved in
differentiation, development, and cell growth arrest (especially Klf4
and Klf2), and they can be induced by cytokines or cell injury
(57). Up-regulation of these transcription factors in
pYV+-infected cells may, thus, play a role in Y. enterocolitica pathogenesis. Furthermore, cluster Q enclosed other
transcription factors that can be involved in cell cycle arrest such as
c-Jun and Dmp1 (22, 29). Hence, in addition to YopM, other pYV-encoded
factors seem to affect the expression of host cell growth regulators.
This illustrates that Y. enterocolitica virulence factors
act in a concerted way and may explain why no clear effect of YopM has been identified so far.
Clusters S and T, which both contained genes down-regulated by a
pYV-encoded factor, enclosed several genes encoding proteins involved
in signaling pathways such as the MAPK (Pip92, A-raf), the Ras pathway
(rap2B), or even the phosphatidylinositol 3-kinase cascade (p85
subunit) (Fig. 4, Table III). It was recently reported that the
phosphatidylinositol 3-kinase could regulate the mRNA expression of
its own p85 subunit (9) so that the alteration of p85 mRNA
expression could result from YopH action on the phosphatidylinositol 3-kinase.2 In addition, YopE, -H, -T, and -O affect Rho
GTPase and focal adhesion proteins at the post-translational level.
Because cross-talks between Ras, Rho, and MAPK signaling pathways have
been described (3), YopE, -H, -T, -O might also be involved in the
mRNA regulation of some of those cascades players.
The analysis of the host cell transcriptome reveals that the
pYV-encoded factors other than YopP and YopM are responsible for the
down-regulation of some pro-inflammatory and cell growth regulator
genes. Furthermore, the induction of mRNA expression for different
members of a transcription factor family suggests that this effect
plays an important role in Y. enterocolitica pathogenesis.
Conclusion--
The identification of the genes affected by the
different Y. enterocolitica virulence factors by mRNA
profiling allowed new insights into the mechanism of action of this
bacterial pathogen. In this analysis, target genes were grouped into
clusters by SOM analysis according to their expression patterns. Many
of those clusters showed homogeneity with regard to the function of the genes they contained. This observation further corroborates the relevance of our analysis and allows a functional interpretation of the data.
The results described herein demonstrate that an important role of the
pYV-encoded factors on the host cell transcriptome is to counteract the
regulations exerted in response to the infection. As expected, this
effect is due in part to YopP, very likely through the inhibition of
the NF- B cascade. However, our results indicate that at least
another pYV-encoded factor participates to the down-regulation of
several genes involved in the onset of inflammation. Besides, our
results reveal that YopM also modulates macrophage gene expression. Unlike the other pYV-encoded factors, YopM does not seem to affect the
inflammatory response; rather, it alters the mRNA expression of
genes involved in the control of the cell cycle and growth regulators.
So far, this is the first in vitro effect described for YopM
on the biology of the infected cell. In addition to YopM, other
pYV-encoded factors (distinct from YopP) may also disturb the mRNA
expression of growth regulators.
Finally, this analysis points out the cooperative effects between the
various factors encoded by the Yop virulon. Concerted actions have been
previously demonstrated between YopE, -H, -T, and -O to avoid bacterial
phagocytosis by macrophages.1 Our analysis reveals that, in
addition, a cooperative scheme has evolved to shut down the host
inflammatory response involving not only YopP but also another
pYV-encoded factor. Besides, different Yops seem to be involved in the
inhibition of host cell growth, YopM and other pYV-encoded factors by
their effect on mRNA expression level of growth and cycle
regulators, as demonstrated here, and YopH via its action on the
phosphatidylinositol 3-kinase activity.2 Altogether these
observations demonstrate the coherent action of the Yop virulon and the
high complexity of Y. enterocolitica pathogenesis.
This analysis constitutes the first case where the use of different
mutated Y. enterocolitica strains together with SOM analysis enabled the identification of genes regulated by the action of distinct
virulence factors. Those genes may constitute potential therapeutic
targets. This analysis provides new clues on the role of the Yop
virulon, which will help to characterize the mechanisms employed by
each Yop in this process.
 |
ACKNOWLEDGEMENTS |
We thank R. Vaqueras for help with microarray
hybridization, M. Obrero with plasmid preparation, and the I.M.A.G.E.
consortium for providing EST plasmids. In addition we thank M. Hahne,
G. Denecker, and J. Mota for critical reading of the manuscript. The
Department of Immunology and Oncology was founded and is supported by
the Spanish Council for Scientific Research (CSIC) and by the Amersham Biosciences.
 |
FOOTNOTES |
*
This work was supported in part by a Training and Mobility
of Researchers Program of the European Community (EU-TMR) Network grant
(Contract ERBFMRXCT980197) (to J. A. G.-S.), Belgian Fonds National
de la Recherche Scientifique Médicale (Convention 3.4595.97), and
the Direction Générale de la Recherche
Scientifique-Communauté Française de Belgique (Action de
Recherche Concertée 94/99-172) (to G. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
¶
A Marie Curie fellow of the European Community
(Contract QLK2-CT-1999-51051). Present address: Unité de
Biologie des Interactions Cellulaires, Institut Pasteur, 75015 Paris, France.

To whom correspondence should be addressed: Biozentrum der
Universität Basel, Klingelbergstrasse 50-70, CH-4056 Basel,
Switzerland. Tel.: 41-61-267-21-10; Fax: 41-61-267-21-18; E-mail
address: guy.cornelis@unibas.ch.
Published, JBC Papers in Press, May 2, 2002, DOI 10.1074/jbc.M203239200
1
Grosdent, N., Maridonneau-Parini, I., Sory, M. P., and Cornelis, G. R. (2002) Infect. Immun., in press.
2
Sauvonnet, N., Lambermont, I., van der Bruggen,
I. P., and Cornelis, G. R. (2002) Mol. Microbiol., in press.
4
J. del Prete, M. S. Robles, A. Guio,
C. Martinez-A, M. Izquierdo, and J. A. Garcia-Sanz, submitted
for publication.
5
M. A. Sanjuán, B. Pradet-Balade,
D. R. Jones, C. Martínez-A, J. A. Garcia-Sanz, and I. Mérida, submitted for publication.
 |
ABBREVIATIONS |
The abbreviations used are:
MAPK, mitogen-activated protein kinase;
TNF, tumor necrosis factor;
SOM, self-organizing map;
IL-1, interleukin 1;
MIP, macrophage inflammatory
protein;
IL-1rn, IL-1 receptor antagonist;
MCPO, monocyte chemotactic
protein.
 |
REFERENCES |
| 1.
|
Cornelis, G. R.,
Boland, A.,
Boyd, A. P.,
Geuijen, C.,
Iriarte, M.,
Neyt, C.,
Sory, M. P.,
and Stainier, I.
(1998)
Microbiol. Mol. Biol. Rev.
62,
1315-1352[Abstract/Free Full Text]
|
| 2.
|
Holmstrom, A.,
Olsson, J.,
Cherepanov, P.,
Maier, E.,
Nordfelth, R.,
Pettersson, J.,
Benz, R.,
Wolf-Watz, H.,
and Forsberg, A.
(2001)
Mol. Microbiol.
39,
620-632[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
| Sahai, E., Olson, M. F., and Marshall, C. J. (2001)
20, 755-766
|
| 4.
|
Dukuzumuremyi, J. M.,
Rosqvist, R.,
Hallberg, B.,
Akerstrom, B.,
Wolf-Watz, H.,
and Schesser, K.
(2000)
J. Biol. Chem.
275,
35281-35290[Abstract/Free Full Text]
|
| 5.
|
Von Pawel-Rammingen, U.,
Telepnev, M.,
Schmidt, G.,
Aktories, K.,
Wolf-Watz, H.,
and Rosqvist, R.
(2000)
Mol. Microbiol.
36,
737-748[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Zumbihl, R.,
Aepfelbacher, M.,
Andor, A.,
Jacobi, C. A.,
Ruckdeschel, K.,
Rouot, B.,
and Heesemann, J.
(1999)
J. Biol. Chem.
274,
29289-29293[Abstract/Free Full Text]
|
| 7.
|
Black, D. S.,
and Bliska, J. B.
(1997)
EMBO J.
16,
2730-2744[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Persson, C.,
Carballeira, N.,
Wolf-Watz, H.,
and Fallman, M.
(1997)
EMBO J.
16,
2307-2318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Lefai, E.,
Roques, M.,
Vega, N.,
Laville, M.,
and Vidal, H.
(2001)
Biochem. J.
360,
117-126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Yao, T.,
Mecsas, J.,
Healy, J. I.,
Falkow, S.,
and Chien, Y.
(1999)
J. Exp. Med.
190,
1343-1350[Abstract/Free Full Text]
|
| 11.
|
Schesser, K.,
Spiik, A. K.,
Dukuzumuremyi, J. M.,
Neurath, M. F.,
Pettersson, S.,
and Wolf-Watz, H.
(1998)
Mol. Microbiol.
28,
1067-1079[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Orth, K.,
Palmer, L. E.,
Bao, Z. Q.,
Stewart, S.,
Rudolph, A. E.,
Bliska, J. B.,
and Dixon, J. E.
(1999)
Science
285,
1920-1923[Abstract/Free Full Text]
|
| 13.
|
Denecker, G.,
Declercq, W.,
Geuijen, C. A.,
Boland, A.,
Benabdillah, R.,
van Gurp, M.,
Sory, M. P.,
Vandenabeele, P.,
and Cornelis, G. R.
(2001)
J. Biol. Chem.
276,
19706-19714[Abstract/Free Full Text]
|
| 14.
|
Ruckdeschel, K.,
Mannel, O.,
Richter, K.,
Jacobi, C. A.,
Trulzsch, K.,
Rouot, B.,
and Heesemann, J.
(2001)
J. Immunol.
166,
1823-1831[Abstract/Free Full Text]
|
| 15.
|
Leung, K. Y.,
Reisner, B. S.,
and Straley, S. C.
(1990)
Infect. Immun.
58,
3262-3271[Abstract/Free Full Text]
|
| 16.
|
Skrzypek, E.,
Cowan, C.,
and Straley, S. C.
(1998)
Mol. Microbiol.
30,
1051-1065[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Subrahmanyam, Y. V.,
Yamaga, S.,
Prashar, Y.,
Lee, H. H.,
Hoe, N. P.,
Kluger, Y.,
Gerstein, M.,
Goguen, J. D.,
Newburger, P. E.,
and Weissman, S. M.
(2001)
Blood
97,
2457-2468[Abstract/Free Full Text]
|
| 18.
|
Sarker, M. R.,
Neyt, C.,
Stainier, I.,
and Cornelis, G. R.
(1998)
J. Bacteriol.
180,
1207-1214[Abstract/Free Full Text]
|
| 19.
|
Mills, S. D.,
Boland, A.,
Sory, M. P.,
van der Smissen, P.,
Kerbourch, C.,
Finlay, B. B.,
and Cornelis, G. R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12638-12643[Abstract/Free Full Text]
|
| 20.
|
Müllner, E. W.,
and Garcia-Sanz, J. A.
(1997)
in
Immunology Methods Manual
(Lefkovits, I., ed), Vol. 1
, pp. 389-406, Academic Press, Inc., London
|
| 21.
|
Müllner, E. W.,
and Garcia-Sanz, J. A.
(1997)
in
Immunology Methods Manual
(Lefkovits, I., ed), Vol. 1
, pp. 407-424, Academic Press, Inc., London
|
| 22.
|
Inoue, K.,
Roussel, M. F.,
and Sherr, C. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3993-3998[Abstract/Free Full Text]
|
| 23.
|
Tamayo, P.,
Slonim, D.,
Mesirov, J.,
Zhu, Q.,
Kitareewan, S.,
Dmitrovsky, E.,
Lander, E. S.,
and Golub, T. R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2907-2912[Abstract/Free Full Text]
|
| 24.
|
Belcher, C. E.,
Drenkow, J.,
Kehoe, B.,
Gingeras, T. R.,
McNamara, N.,
Lemjabbar, H.,
Basbaum, C.,
and Relman, D. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
13847-13852[Abstract/Free Full Text]
|
| 25.
|
Cohen, P.,
Bouaboula, M.,
Bellis, M.,
Baron, V.,
Jbilo, O.,
Poinot-Chazel, C.,
Galiegue, S.,
Hadibi, E. H.,
and Casellas, P.
(2000)
J. Biol. Chem.
275,
11181-11190[Abstract/Free Full Text]
|
| 26.
|
Eckmann, L.,
Smith, J. R.,
Housley, M. P.,
Dwinell, M. B.,
and Kagnoff, M. F.
(2000)
J. Biol. Chem.
275,
14084-14094[Abstract/Free Full Text]
|
| 27.
|
Griffin, F. M., Jr.,
Griffin, J. A.,
Leider, J. E.,
and Silverstein, S. C.
(1975)
J. Exp. Med.
142,
1263-1282[Abstract/Free Full Text]
|
| 28.
|
Niinobu, T.,
Fukuo, K.,
Yasuda, O.,
Tsubakimoto, M.,
Mogi, M.,
Nishimaki, H.,
Morimoto, S.,
and Ogihara, T.
(2000)
Am. J. Physiol. Cell Physiol.
279,
504-509
|
| 29.
|
Bossy-Wetzel, E.,
Bakiri, L.,
and Yaniv, M.
(1997)
EMBO J.
16,
1695-1709[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Dube, P. H.,
Revell, P. A.,
Chaplin, D. D.,
Lorenz, R. G.,
and Miller, V. L.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
10880-10885[Abstract/Free Full Text]
|
| 31.
|
Boland, A.,
and Cornelis, G. R.
(1998)
Infect. Immun.
66,
1878-1884[Abstract/Free Full Text]
|
| 32.
|
Locksley, R. M.,
Killeen, N.,
and Lenardo, M. J.
(2001)
Cell
104,
487-501[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Pahl, H. L.
(1999)
Oncogene
18,
6853-6866[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Kimball, S. R.
(1999)
Int. J. Biochem. Cell Biol.
31,
25-29[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Quevedo, C.,
Alcazar, A.,
and Salinas, M.
(2000)
J. Biol. Chem.
275,
19192-19197[Abstract/Free Full Text]
|
| 36.
|
Pap, M.,
and Cooper, G. M.
(2002)
Mol. Cell. Biol.
22,
578-586[Abstract/Free Full Text]
|
| 37.
|
Kassel, O.,
Sancono, A.,
Kratzschmar, J.,
Kreft, B.,
Stassen, M.,
and Cato, A. C.
(2001)
EMBO J.
20,
7108-7116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Druey, K. M.,
Blumer, K. J.,
Kang, V. H.,
and Kehrl, J. H.
(1996)
Nature
379,
742-746[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Grigoryev, S.,
Stewart, A. E.,
Kwon, Y. T.,
Arfin, S. M.,
Bradshaw, R. A.,
Jenkins, N. A.,
Copeland, N. G.,
and Varshavsky, A.
(1996)
J. Biol. Chem.
271,
28521-28532[Abstract/Free Full Text]
|
| 40.
|
Gaudry, C. A.,
Palka, H. L.,
Dusek, R. L.,
Huen, A. C.,
Khandekar, M. J.,
Hudson, L. G.,
and Green, K. J.
(2001)
J. Biol. Chem.
276,
24871-24880[Abstract/Free Full Text]
|
| 41.
|
Yao, X.,
Buermeyer, A. B.,
Narayanan, L.,
Tran, D.,
Baker, S. M.,
Prolla, T. A.,
Glazer, P. M.,
Liskay, R. M.,
and Arnheim, N.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6850-6855[Abstract/Free Full Text]
|
| 42.
|
Bartek, J.,
Falck, J.,
and Lukas, J.
(2001)
Nat. Rev. Mol. Cell Biol.
2,
877-886[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Ridgway, P.,
and Almouzni, G.
(2000)
J. Cell Sci.
113,
2647-2658[Abstract]
|
| 44.
|
Bies, J.,
Hoffman, B.,
Amanullah, A.,
Giese, T.,
and Wolff, L.
(1996)
Oncogene
12,
355-363[Medline]
[Order article via Infotrieve]
|
| 45.
|
Liscovitch, M.,
Czarny, M.,
Fiucci, G.,
and Tang, X.
(2000)
Biochem. J.
345,
401-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Hata, Y.,
and Sudhof, T. C.
(1995)
J. Biol. Chem.
270,
13022-13028[Abstract/Free Full Text]
|
| 47.
|
Horikawa, I.,
Parker, E. S.,
Solomon, G. G.,
and Barrett, J. C.
(2001)
J. Cell. Biochem.
82,
415-421[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Seipel, K.,
Medley, Q. G.,
Kedersha, N. L.,
Zhang, X. A.,
O'Brien, S. P.,
Serra-Pages, C.,
Hemler, M. E.,
and Streuli, M.
(1999)
J. Cell Sci.
112,
1825-1834[Abstract]
|
| 49.
|
Gale, M. J.,
Blakely, C. M.,
Hopkins, D. A.,
Melville, M. W.,
Wambach, M.,
Romano, P. R.,
and Katze, M. G.
(1998)
Mol. Cell. Biol.
18,
859-871[Abstract/Free Full Text]
|
| 50.
|
Graham, I. L.,
Gresham, H. D.,
and Brown, E. J.
(1989)
J. Immunol.
142,
2352-2358[Abstract]
|
| 51.
|
Panetta, R.,
Guo, Y.,
Magder, S.,
and Greenwood, M. T.
(1999)
Biochem. Biophys. Res. Commun.
259,
550-556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Zavizion, B.,
White, J. H.,
and Bramley, A. J.
(1997)
J. Infect. Dis.
176,
1637-1640[Medline]
[Order article via Infotrieve]
|
| 53.
|
Sing, A.,
Roggenkamp, A.,
Geiger, A. M.,
and Heesemann, J.
(2002)
J. Immunol.
168,
1315-1321[Abstract/Free Full Text]
|
| 54.
|
Alberta, J. A.,
Auger, K. R.,
Batt, D.,
Iannarelli, P.,
Hwang, G.,
Elliott, H. L.,
Duke, R.,
Roberts, T. M.,
and Stiles, C. D.
(1999)
J. Biol. Chem.
274,
31062-31067[Abstract/Free Full Text]
|
| 55.
|
Kelley, T. W.,
Graham, M. M.,
Doseff, A. I.,
Pomerantz, R. W.,
Lau, S. M.,
Ostrowski, M. C.,
Franke, T. F.,
and Marsh, C. B.
(1999)
J. Biol. Chem.
274,
26393-26398[Abstract/Free Full Text]
|
| 56.
|
Dunn, S. E.,
Torres, J. V., Oh, J. S.,
Cykert, D. M.,
and Barrett, J. C.
(2001)
Cancer Res.
61,
1367-1374[Abstract/Free Full Text]
|
| 57.
|
Bieker, J. J.
(2001)
J. Biol. Chem.
276,
34355-34358[Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Chuchana, D. Marchand, M. Nugoli, C. Rodriguez, N. Molinari, and J. A. Garcia-Sanz
An adaptation of the LMS method to determine expression variations in profiling data
Nucleic Acids Res.,
May 14, 2007;
35(9):
e71 - e71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. O'Grady, H. Mulcahy, J. O'Callaghan, C. Adams, and F. O'Gara
Pseudomonas aeruginosa Infection of Airway Epithelial Cells Modulates Expression of Kruppel-Like Factors 2 and 6 via RsmA-Mediated Regulation of Type III Exoenzymes S and Y.
Infect. Immun.,
October 1, 2006;
74(10):
5893 - 5902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Handley, P. H. Dube, and V. L. Miller
From the Cover: Histamine signaling through the H2 receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection
PNAS,
June 13, 2006;
103(24):
9268 - 9273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Heusipp, K. Spekker, S. Brast, S. Falker, and M. A. Schmidt
YopM of Yersinia enterocolitica specifically interacts with {alpha}1-antitrypsin without affecting the anti-protease activity.
Microbiology,
May 1, 2006;
152(Pt 5):
1327 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. van Erp, K. Dach, I. Koch, J. Heesemann, and R. Hoffmann
Role of strain differences on host resistance and the transcriptional response of macrophages to infection with Yersinia enterocolitica
Physiol Genomics,
March 13, 2006;
25(1):
75 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, A. T. Ting, K. B. Marcu, and J. B. Bliska
Inhibition of MAPK and NF-{kappa}B Pathways Is Necessary for Rapid Apoptosis in Macrophages Infected with Yersinia
J. Immunol.,
June 15, 2005;
174(12):
7939 - 7949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Schotte, G. Denecker, A. Van Den Broeke, P. Vandenabeele, G. R. Cornelis, and R. Beyaert
Targeting Rac1 by the Yersinia Effector Protein YopE Inhibits Caspase-1-mediated Maturation and Release of Interleukin-1{beta}
J. Biol. Chem.,
June 11, 2004;
279(24):
25134 - 25142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. E. Rodriguez, H. K. Chang, and M. E. Wilson
Novel Program of Macrophage Gene Expression Induced by Phagocytosis of Leishmania chagasi
Infect. Immun.,
April 1, 2004;
72(4):
2111 - 2122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shiratsuchi, I. Watanabe, O. Takeuchi, S. Akira, and Y. Nakanishi
Inhibitory Effect of Toll-Like Receptor 4 on Fusion between Phagosomes and Endosomes/Lysosomes in Macrophages
J. Immunol.,
February 15, 2004;
172(4):
2039 - 2047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. McMorran, L. Town, E. Costelloe, J. Palmer, J. Engel, D. Hume, and B. Wainwright
Effector ExoU from the Type III Secretion System Is an Important Modulator of Gene Expression in Lung Epithelial Cells in Response to Pseudomonas aeruginosa Infection
Infect. Immun.,
October 1, 2003;
71(10):
6035 - 6044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Brubaker
Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen)
Infect. Immun.,
July 1, 2003;
71(7):
3673 - 3681.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. McDonald, P. O. Vacratsis, J. B. Bliska, and J. E. Dixon
The Yersinia Virulence Factor YopM Forms a Novel Protein Complex with Two Cellular Kinases
J. Biol. Chem.,
May 9, 2003;
278(20):
18514 - 18523.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|